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During the past few years there has been an outgrowth of research designed 
to elucidate the intricate relationships that appear to exist between the immune 
and  neuroendocrine  systems (1-4).  The postulated lymphoid-adrenal  axis pro- 
vides  the  most  fascinating  example  of this  concept.  Infection  with  Newcastle 
disease virus (NDV) augments plasma glucocorticoid concentrations  in hypoph- 
ysectomized mice (5). Indirect immunofluorescence studies with splenocytes from 
NDV-infected  mice  showed positive cytoplasmic staining  with  an  antibody di- 
rected against adrenocorticotropic hormone (ACTH  1-13 amide). This finding 
suggested that splenocytes can synthesize a cytokine that is identical to pituitary- 
derived ACTH.  The lymphocyte-derived ACTH is similar to pituitary-derived 
ACTH  in  regard  to its  biological activity,  molecular  weight,  antigenicity,  and 
retention time on a reverse phase HPLC column (6-8), but its structural identity 
to pituitary-derived ACTH has not yet been proven. 
ACTH  is  derived  from  the  31-kD  precursor  protein  proopiomelanocortin 
(POMC), as is a-, 3'-, /3-melanotropin,  /3- and 3,-lipotropin  and/3-endorphin  (9). 
Immunoreactive  /3-endorphin  also  has  been  shown  to  exist  in  virus-infected 
lymphocytes (7). Glucocorticoids inhibit cytoplasmic staining of immunoreactive 
ACTH and/3-endorphin  in  NDV-infected lymphocytes, while corticotropin  re- 
leasing factor (CRF) enhances de novo synthesis of ACTH and/3-endorphin  (10). 
These results suggest that POMC gene products are expressed in lymphoid cells 
and that they are regulated in a similar manner as POMC gene products in the 
anterior pituitary gland. If this concept is true, lymphoid cells infected with virus, 
but  not  noninfected  cells,  should  synthesize  the  POMC  precursor  protein. 
Demonstration  of specific POMC  mRNA in  virus-infected  lymphocytes would 
provide evidence in support of this hypothesis. We report here that virus-infected 
murine  splenocytes contain  poly(A)  + cytoplasmic  RNA  that  hybridizes  with  a 
cDNA probe that contains the entire coding sequence for murine POMC. These 
results offer the first evidence using molecular hybridization that lymphoid cells 
can be activated to express the POMC. 
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Materials and Methods 
RNA Analysis.  Splenocytes were isolated from 4-8-wk-old Balb/c mice and incubated 
in the absence or presence of NDV (10 hemagglutination U/106 cells) for 18 h at 39°C, 
7% CO~. Total cellular RNA was extracted by the guanidinium/hot phenol method (11), 
cytoplasmic RNA was isolated (12), and poly(A)  + RNA purified by oligo(dT) chromatog- 
raphy (13). Total cellular and poly(A)  + cytoplasmic RNA from ART-20 cells, noninfected 
splenocytes, and NDV-infected splenocytes were blotted onto Gene Screen membranes 
(New England Nuclear, Boston, MA). Transfer membranes were baked for 2 h at 80°C. 
Prehybridization of the membranes was in 50% formamide, 0.2% polyvinyl-pyrrolidone, 
0.2% BSA, 0.2% ficoll, 0.05 M Tris-HC1, 1.0 M NaCt, 0.1% sodium pyrophosphate, 1% 
SDS,  10% dextran sulfate, and denatured salmon sperm DNA (>100/~g/ml) for 16-20 h 
at 42°C.  Hybridization was in 50% formamide, 0.2% polyvinyl-pyrrolidone, 0.2% BSA, 
0.2% ficoll, 0.05 M Tris-HCl, 0.1% sodium phosphate, 1% SDS, denatured salmon sperm 
DNA,  and the ~-~2pdCTP-labeled pMKSU16 plasmid  for 24 h  at 42°C.  This plasmid 
contains a  1,026 bp insert that contains the entire coding sequence of murine  POMC 
(14).  Gene Screen membranes were washed sequentially with agitation twice in 2x SSC 
(0.3 M sodium chloride, 0.03 M sodium citrate) for 15 min at room temperature, twice 
in 2x SSC with  t% SDS for 60 min at 65°C, and twice in 0.1x SSC for 30 min at room 
temperature. Membranes were dried and exposed to XAR-5 film (Eastman Kodak Co., 
Rochester, NY) for 48 h at -80 ° C before development of autoradiographs. The cDNA 
insert for POMC was not purified from the recombinant plasmid, pMKSUI 6, since this 
plasmid (pBR322) without the insert did not hybridize to RNA isolated from either AtT- 
20 cells, noninfected, or NDV-infected splenocytes (data not shown). For Northern blot 
analysis,  poly(A)  + cytoplasmic RNA was denatured with glyoxal and electrophoresed in a 
1.2% agarose gel (15) in 0.01  M sodium phosphate (pH 6.5) before transfer onto Gene 
Screen membranes. 
Results 
If ACTH  is synthesized by splenocytes according to the same process as that 
which  takes  place  in  the  pituitary  gland,  it  should  be  possible  to  show  that 
infection of lymphoid cells with a  virus leads to expression of the POMC  gene. 
To test  this possibility, total cellular RNA  from  NDV-infected splenocytes was 
isolated and hybridized with the recombinant plasmid, pMKSU 16, which contains 
the POMC  insert (Fig.  1,  lane 3).  Positive hybridization was detected with total 
cellular RNA from NDV-infected splenocytes and a positive control, the ACTH- 
secreting AtT-20 pituitary tumor cell line (Fig.  1, lane 1). This hybridization was 
specific for total cellular RNA  from NDV-infected splenocytes since the probe 
did  not  hybridize to  total cellular  RNA  from noninfected splenocytes (Fig.  1, 
lane  2)  or from mouse  liver (data  not  shown).  Positive hybridization by RNA 
from NDV-infected splenocytes was not due to crosshybridization of the cDNA 
probe  to  the  NDV  virus  because  RNA  isolated  from  the  NDV  virus  did  not 
hybridize to pMKSU 16 containing the POMC insert (data not shown). 
To  determine  if there  was  specific  mRNA  for  POMC  in  the  cytoplasm  of 
NDV-infected splenocytes, poly(A)  + cytoplasmic RNA  was purified. There was 
positive hybridization of poly(A)  ÷ cytoplasmic RNA from NDV-infected spleno- 
cytes (Fig.  1, lane 6) and from the positive control, AtT-20 cells (Fig.  1, lane 4). 
When  equal concentrations of RNA  were dot blotted onto Gene Screen mem- 
branes,  there was a  greater amount of hybridization of both total cellular and 
poly(A)  + RNA from AtT-20 pituitary cells than from NDV-infected splenocytes 
(Fig.  1,  lanes  1 and  3  vs.  lanes  4  and  6,  respectively). Noninfected splenocytes 
did not contain  specific mRNA  for the  POMC  gene (Fig.  1,  lane 5).  Northern WESTLY ET  AL.  BRIEF  DEFINITIVE  REPORT  1591 
FIGURE  1.  Hybridization of the recombinant plasmid, pMKSU16, which contains an insert 
coding for the entire mouse POMC  sequence  (16), to decreasing  concentrations  of total cellular 
RNA (20 ~tg, 10 ~tg, 5/zg) isolated from AtT-20 cells (lane 1), noninfected splenocytes  (lane 
2) and NDV-infected splenocytes  (lane 3), and to poly(A)  ÷ cytoplasmic  RNA (10 ~g, 5 ~g, 1 
ug) from AtT-20 cells (lane 4), noninfected splenocytes  (lane 5), and NDV-infected  splenocytes 
(lane 6). 
blot analysis revealed that molecular size of POMC mRNA from NDV-infected 
splenocytes was similar to mRNA that was isolated from AtT-20 pituitary cells 
(Fig. 2, lanes 3 and 1). No specific mRNA from splenocytes cultured for 18 h  in 
the absence of virus could be detected by Northern blot analysis (Fig. 2, lane 2). 
Discussion 
Until  now, it has only been assumed that lymphocyte-derived ACTH and/3- 
endorphin are  POMC  gene products.  Since IFN-ct is also synthesized by virus- 
infected lymphoid cells, it could be argued  that lymphocyte-derived ACTH  is 
synthesized  from  a  gene  sequence  within  the  family of genes  that  codes  for 
interferon proteins. However, there are no common nucleotide sequences shared 
by the cloned IFNs and POMC cDNA (14,  16).  This finding could indicate that 
the cDNA probe  used in this study hybridized to a  POMC-like mRNA and not 
to an IFN-a mRNA. Therefore, these data provide direct evidence for expression 
of a  POMC-like gene in virus-infected splenocytes. 
Earlier studies using indirect immunofluorescence with ACTH and/3-endor- 
phin antibodies (7) have shown that nearly all of the human PBMC infected with 
NDV are positive.  Both lymphocytes (7)  and macrophages (17)  may synthesize 
immunoreactive ACTH, which suggests that all virus-infected lymphoid cells can 
express the POMC gene. The percentage of positive cells may be dependent on 
the number of splenocytes that are actually infected with the virus, which would 
explain the coordinate expression of the IFN-c~ genes and the POMC gene (7). 
We are presently using cloned T,  B and macrophage cell lines to determine if 
different activating signals can  induce lymphoid cell subpopulations  to express 
the POMC gene. 1592  WESTLY  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIGURE 2.  Northern  blot analysis of poly(A)  + cytoplasmic RNA isolated from AtT-20 cells 
(lane 1, 0.50 #g), noninfected splenocytes (Jane 2, 6.5 #g), and NDV-infected splenocytes (lane 
3,  14 #g). 
The physiological significance of hormone secretion by lymphoid cells may be 
to serve as an  afferent signal  to  the central nervous system or a  target organ 
during viral or bacterial invasion. Synthesis and secretion of biologically active 
ACTH  from  lymphocytes would  signal  the  adrenal  gland  to  synthesize and 
secrete glucocorticoids. This possibility has been shown  in  vivo with a  patient 
bearing an  ectopic,  ACTH-secreting lymphocytic tumor (18).  Glucocorticoids 
are well known to play an important physiological role in lymphocyte regulation 
(19-21).  It also is possible that hormones secreted by activated lymphocytes act 
as  paracrine  immunomodulators in  their own  microenvironment. ACTH  has 
been shown to synergize with B cell growth and differentiation factors to augment 
B cell proliferation and differentiation (22) and to inhibit IFN-~/production (23). 
~-endorphin increases the proliferative response of lymphocytes to T  cell mito- 
gens (24),  enhances natural  cytotoxicity and  IFN  production by natural  killer 
cells (25, 2B), and stimulates chemotaxis of human PBMC (27). Enkephalins have 
common amino acid sequences to peptides derived from POMC (28) and these 
endogenous opioid peptides have also been shown to modulate immune events 
(29).  Furthermore, lymphoid cells possess specific receptors for ACTH  and 8- 
endorphin (30,  31).  Thus, there is substantial support for the idea that POMC 
gene products directly affect functional activities of lymphoid cells. Future studies 
aimed at understanding the process by which lymphocytes may become activated 
to synthesize mRNA for hormone precursors, translate this message into protein, 
process  the  precursor  protein  into  active  hormone  peptides,  and  eventually WESTLY ET  AL.  BRIEF  DEFINITIVE  REPORT  1593 
secrete these peptides will increase the understanding of systems of communica- 
tion between the nervous, endocrine and immune systems. 
Summary 
Infection of murine splenocytes with Newcastle disease virus results in expres- 
sion of the proopiomelanocortin gene as determined by dot and northern blot 
analysis of total cellular and poly(A)  ÷ cytoplasmic RNA. These data provide the 
first evidence that  the precursor protein for adrenocorticotropin and fl-endor- 
phin can be synthesized by lymphoid cells. 
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